Gastroenterology Research and Practice / 2009 / Article / Tab 1

Clinical Study

Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function

Table 1

Patient characteristics at baseline.

Patient IDGender/age (years)/diagnosisBody mass index (kg/m2)Small bowel (cm)Colon-in cont. (%)Time since last surgery (years)Wet weight intake (kg/d)Fecal wet weight excretion (kg/d)Parenteral fluid (L/d)Diet energy intake (MJ/d)Fecal energy excretion (MJ/d)Patenteral energy (MJ/d)Duration of HPN (years)Time on GLP-2(days, 2 years)

HRMF/47/CD 0.82.5
LMM/27/CD 6.42.5
OBM/49/CD 0.011.6 Abd. pain
GLM/53/CD nono
JPM/24/CD Abd. pain
EFPF/55/CD unrel. feedback
JEM/44/UC compl. nono
JHJM/55/UC compl.
UDJF/50/UC compl.
JVM/67/CD nono
FVLM/59/CD nono

M: male, F: female, CD: Crohns disease, UC compl.: Ulcerative colitis complications, Abd. Pain: Abdominal pain, Unrel. Feedback: Unreliable feedback.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.